MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202617065805 A) filed by Zedira Gmbh on May 25, 2026, for Oxo-Pyridine Derivatives As Inhibitors Of Transglutaminases For Use In The Treatment Of Pulmonary Fibrosis.
Inventors include Pasternack, Ralf; Bchold, Christian; Hils, Martin; Gerlach, Uwe; and Florian, Peter.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: The invention relates to specifically selected inhibitors of transglutaminase 2 (TG2), which are oxopyridine derivatives of formula (I), useful for the treatment of pulmonary inflammation, pulmonary fibrosis, in particular idiopathic pulmonary fibrosis.
Disclaimer: Curated by HT Syndicati...